^Galeotti, N.; Ghelardini, C.; Pittaluga, A.; Pugliese, A.; Bartolini, A.; Manetti, D.; Romanelli, M.; Gualtieri, F. (2003). „AMPA-receptor activation is involved in the antiamnesic effect of DM 232 (unifiram) and DM 235 (sunifiram)”. Naunyn-Schmiedeberg's archives of pharmacology. 368 (6): 538—545. PMID14600801. doi:10.1007/s00210-003-0812-6.
^Ghelardini, C.; Galeotti, N.; Gualtieri, F.; Romanelli, M.; Bucherelli, C.; Baldi, E.; Bartolini, A. (2002). „DM235 (sunifiram): a novel nootropic with potential as a cognitive enhancer”. Naunyn-Schmiedeberg's archives of pharmacology. 365 (6): 419—426. PMID12070754. doi:10.1007/s00210-002-0577-3.
^Romanelli, M.; Galeotti, N.; Ghelardini, C.; Manetti, D.; Martini, E.; Gualtieri, F. (2006). „Pharmacological characterization of DM232 (unifiram) and DM235 (sunifiram), new potent cognition enhancers”. CNS Drug Reviews. 12 (1): 39—52. PMID16834757. doi:10.1111/j.1527-3458.2006.00039.x.
